POLI:TASEBank Hapoalim BM Analysis
Data as of 2026-06-12 - not real-time
$6.60
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Polibeli Group Ltd (POLI) trades at $6.60, just above its 20‑day SMA (6.57) but well below the 50‑day (7.12) and 200‑day (8.72) averages, signaling a bearish price trend. The MACD is negative and the histogram remains in bearish territory, while the RSI sits at 49.9, indicating no momentum support. Volatility is extreme at 81.7% over the past 30 days, and the stock has endured a 55.5% max drawdown, reflecting high price swings. On the fundamentals side, revenue jumped 61% YoY to $26.4 M, yet gross margins are only 7.3% and operating margins are –24.7%, resulting in a net loss and negative EPS of –$0.02. The balance sheet shows negative book value per share (‑$0.124) and a price‑to‑book ratio of –53, while the price‑to‑sales ratio is an inflated 91.5, underscoring an overvalued market price. Cash balances ($3.09 M) barely cover the operating cash outflow (‑$6.35 M), and free cash flow is also negative, raising concerns about sustainability.
The sector—Consumer Cyclical Department Stores—is highly sensitive to discretionary spending, adding medium to high sector risk, and the company’s multi‑regional exposure (Japan, Indonesia, Hong Kong, Europe) introduces medium geographic and currency risks. Despite increasing trading volume, the combination of weak profitability, high valuation multiples, and extreme market sentiment (Extreme Greed index 86.7) suggests caution, with short‑term downside pressure likely while any long‑term upside hinges on a successful turnaround of margins and cash flow.
The sector—Consumer Cyclical Department Stores—is highly sensitive to discretionary spending, adding medium to high sector risk, and the company’s multi‑regional exposure (Japan, Indonesia, Hong Kong, Europe) introduces medium geographic and currency risks. Despite increasing trading volume, the combination of weak profitability, high valuation multiples, and extreme market sentiment (Extreme Greed index 86.7) suggests caution, with short‑term downside pressure likely while any long‑term upside hinges on a successful turnaround of margins and cash flow.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below 50‑day and 200‑day SMAs with bearish MACD
- Negative operating margins and cash flow
- Extreme volatility and recent large drawdown
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth (61% YoY) indicating potential upside
- Continued negative profitability and high valuation multiples
- Increasing trading volume suggesting market interest
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential for margin improvement through digital supply‑chain efficiencies
- Persistent negative equity and high price‑to‑sales ratio
- Exposure to multiple geographic markets balancing growth and risk
Key Metrics & Analysis
Financial Health
Revenue Growth61.10%
Profit Margin-22.60%
ROA-24.50%
P/B Ratio-53.2
Op. Cash Flow$-6354919
Free Cash Flow$-199612
Technical Analysis
TrendBearish
RSI49.9
Support$5.21
Resistance$8.00
MA 20$6.57
MA 50$7.12
MA 200$8.72
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta-0.24
Volatility81.73%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.